Hepatitis C IgG

Description: 
Qualitative chemiluminescent immunoassay (CLIA) for Hepatitis C IgG antibodies. Reactive samples undergo further testing to establish status, diagnose chronic hepatitis C infection or test recipient at set intervals following body fluid exposure incident. This assay is available routinely Mon to Sun.

This test is not UKAS accredited
Clinical details: 
asymptomatic
body fluid exposure
abnormal LFTs
chronic hepatitis
Related condition or disease: 
asymptomatic
hepatitis
chronic hepatitis
cirrhosis
hepatocellular carcinoma
endemic region
IVDU
MSM
Reference range: 

Detected, Not detected, Equivocal A negative HCV IgG does not exclude acute hepatitis C infection as seroconversion may be delayed. If you consider the patient to have risk factors for HCV infection, please send a repeat clotted blood sample for hepatitis C antibodies, and telephone the laboratory to discuss HCV RNA testing (EDTA blood sample)

Synonyms or keywords: 
HepC HCV blood borne virus body fluid exposure hepatitis chronic hepatitis cirrhosis hepatocellular carcinoma endemic region IVDU MSM
Department: 
Infection Sciences Department
Location: 
Blackfriar's Hub
Sample type and Volume required: 
2.5 – 5ml Yellow Top Serum Separation Tube (SST) Clotted Blood (for serum).
Turnaround time: 
3 to 5 working days
Criteria for acceptance / rejections of sample
Storage and transport: 
Place labelled sample in a sealed sample bag and send to Central Specimen Reception (CSR). To prevent sample haemolysis please store samples in refrigerator if a delay in sending samples to CSR is unavoidable.
Contacts:
For clinical advice or interpretation of results, please contact the laboratory in the first instance.
Laboratory: 
Virology Laboratory at Blackfriars Hub

Print as a PDF

Last updated: 18/12/2024